BioArctic gets approval to initiate Leqembi subcutaneous treatment in China
BioArctic AB says Leqembi’s subcutaneous formulation has been approved for initiation treatment in China.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.